104 related articles for article (PubMed ID: 8879879)
41. [Dopamine-D2 receptor scintigraphy with 123I-iodobenzofuran in malignant melanoma].
Steinert H; Huch-Böni RA; Böni R; Westera G; Buck A
Nuklearmedizin; 1995 Aug; 34(4):146-50. PubMed ID: 7675644
[TBL] [Abstract][Full Text] [Related]
42. A patient study with radioiodine labelled 5-iodo-2-thiouracil.
van Langevelde A; Bergman W; Feitsma RI; Osanto S; Pauwels EK
Eur J Nucl Med; 1988; 14(12):640-1. PubMed ID: 3243315
[No Abstract] [Full Text] [Related]
43. 3'-18F-fluoro-3'-deoxy-L-thymidine: a new tracer for staging metastatic melanoma?
Cobben DC; Jager PL; Elsinga PH; Maas B; Suurmeijer AJ; Hoekstra HJ
J Nucl Med; 2003 Dec; 44(12):1927-32. PubMed ID: 14660718
[TBL] [Abstract][Full Text] [Related]
44. Neuroblastoma stage 4S with 123I-MIBG-positive bone marrow involvement.
Hufnagel M; Claviez A; Czech N; Schmidt M; Hero B
Pediatr Blood Cancer; 2006 Feb; 46(2):264-5. PubMed ID: 16078224
[No Abstract] [Full Text] [Related]
45. Bone marrow localisation of metastatic melanoma and synchronous leukaemic evolution of low-risk myelodysplastic syndrome.
Ferla V; Freyrie A; Guidotti F; Bonoldi E; Gianelli U; Cortelezzi A
J Clin Pathol; 2013 Jan; 66(1):75-8. PubMed ID: 23019351
[No Abstract] [Full Text] [Related]
46. Diffuse bone marrow involvement of Hodgkin lymphoma mimics hematopoietic cytokine-mediated FDG uptake on FDG PET imaging.
Chiang SB; Rebenstock A; Guan L; Alavi A; Zhuang H
Clin Nucl Med; 2003 Aug; 28(8):674-6. PubMed ID: 12897658
[TBL] [Abstract][Full Text] [Related]
47. Malignant melanoma metastatic to bone marrow.
Basu D; Bhade BA; Ghotekar LH; Mathew T; Dutta TK
Indian J Pathol Microbiol; 2002 Jan; 45(1):107-9. PubMed ID: 12593576
[TBL] [Abstract][Full Text] [Related]
48. [A case of an adult neuroblastoma with bone-marrow metastases: 131I-MIBG scintigraphy in comparison with MRI].
Koda M; Okamura T; Kobashi T; Kawabe J; Ochi H; Yamada R; Hino M
Kaku Igaku; 1997 Sep; 34(9):821-6. PubMed ID: 9394549
[TBL] [Abstract][Full Text] [Related]
49. The potential use of I-123 IMP scintigraphy for pelvic bone metastases in hepatocellular carcinoma. A comparison with Ga-67 scintigraphy.
Suto Y; Tanigawa N; Iwamiya T; Shabana M; Ohta Y
Clin Nucl Med; 1994 Apr; 19(4):302-6. PubMed ID: 8004860
[TBL] [Abstract][Full Text] [Related]
50. [Scintigraphy of malignant melanoma].
Ito K; Hisamatsu K; Nakada K; Tsukamoto E; Furudate M
Rinsho Hoshasen; 1988 Feb; 33(2):303-4. PubMed ID: 3164426
[No Abstract] [Full Text] [Related]
51. [A case of choroidal malignant melanoma in which 123I-IMP scintigraphy was useful for diagnosis].
Kotake F; Kawanishi M; Ishii I; Akata S; Kakizaki D; Abe K
Kaku Igaku; 1998 Jul; 35(6):427-33. PubMed ID: 9753922
[TBL] [Abstract][Full Text] [Related]
52. [Clinical usefulness of 123I-IMP scintigraphy in the diagnosis of bone metastases from hepatocellular carcinoma: comparison with 99mTc-MDP bone scintigraphy].
Suto Y; Tanigawa N; Iwamiya T; Kato T; Endo K; Shabana M; Ohta Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Aug; 53(8):953-9. PubMed ID: 8396760
[TBL] [Abstract][Full Text] [Related]
53. Iodine-123 IMP uptake in brain metastases from lung cancer.
Szasz IJ; Lyster D; Morrison RT
J Nucl Med; 1985 Nov; 26(11):1342-3. PubMed ID: 2997420
[No Abstract] [Full Text] [Related]
54. Immunocytological detection of isolated tumour cells in the bone marrow of malignant melanoma patients: a new method for the detection of minimal residual disease.
Thybusch-Bernhardt A; Klomp HJ; Maas T; Kremer B; Juhl H
Eur J Surg Oncol; 1999 Oct; 25(5):498-502. PubMed ID: 10527598
[TBL] [Abstract][Full Text] [Related]
55. A case of bone marrow recurrence from gastric carcinoma after a nine-year disease-free interval.
Noda N; Sano T; Shirao K; Ono H; Katai H; Sasako M; Maruyama K
Jpn J Clin Oncol; 1996 Dec; 26(6):472-5. PubMed ID: 9001355
[TBL] [Abstract][Full Text] [Related]
56. Limitation in the assessment of baseline lymphomatous bone marrow involvement by FDG-PET/CT scan.
Hong J; Lee JH
Ann Hematol; 2013 Apr; 92(4):565-6. PubMed ID: 23086509
[No Abstract] [Full Text] [Related]
57. Using a cut-off SUV level to define bone marrow lesions on FDG PET is not appropriate.
Cheng G
Ann Hematol; 2013 Jan; 92(2):283-4. PubMed ID: 22885991
[No Abstract] [Full Text] [Related]
58. Tc-99m MIBI localization in bone marrow: a marker of bone marrow malignancy.
Wakasugi S; Teshima H; Nakamura H; Hashizume T; Maeda T; Hiraoka A; Hasegawa Y; Masaoka T
Clin Nucl Med; 1998 Oct; 23(10):664-71. PubMed ID: 9790040
[TBL] [Abstract][Full Text] [Related]
59. [Scintigraphy using I 131 iodobenzylguanidine and malignant melanomas].
de Both PS; De Groot GH; Hoefnagel CA
Ned Tijdschr Geneeskd; 1990 Oct; 134(42):2054-7. PubMed ID: 2234180
[TBL] [Abstract][Full Text] [Related]
60. [Dynamic sequential scintigraphy using I-123-IMP in patients with intracranial mass lesions, a comparison with the Xe-133 method].
Hoshi H; Jinnouchi S; Watanabe K; Harada K; Onoe K; Kinoshita K; Ueda T; Yamaoka N
Kaku Igaku; 1986 Jun; 23(6):819-24. PubMed ID: 3761734
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
